peonidin has been researched along with pelargonidin-3-glucoside in 1 studies
| Studies (peonidin) | Trials (peonidin) | Recent Studies (post-2010) (peonidin) | Studies (pelargonidin-3-glucoside) | Trials (pelargonidin-3-glucoside) | Recent Studies (post-2010) (pelargonidin-3-glucoside) |
|---|---|---|---|---|---|
| 49 | 1 | 37 | 55 | 2 | 43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calibasi-Kocal, G; Ellidokuz, H; Kurter, H; Mert-Ozupek, N | 1 |
1 other study(ies) available for peonidin and pelargonidin-3-glucoside
| Article | Year |
|---|---|
In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.
Topics: Anthocyanins; Humans; Molecular Docking Simulation; Transforming Growth Factor beta | 2022 |